L3VLUP
ProSign in

CNMD · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CNMDJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CNMD
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterCNMDJNJ
Q3 202010 holders, $208m30 holders, $26.2bn
Q4 20206 holders, $180m32 holders, $26.6bn
Q1 20217 holders, $171m31 holders, $25.3bn
Q2 20214 holders, $185m37 holders, $25.6bn
Q3 20216 holders, $173m40 holders, $24.1bn
Q4 20213 holders, $179m33 holders, $25.2bn
Q1 20226 holders, $233m35 holders, $28.2bn
Q2 20225 holders, $180m33 holders, $26.9bn
Q3 20225 holders, $153m36 holders, $25.4bn
Q4 20225 holders, $209m35 holders, $27.6bn
Q1 20235 holders, $268m42 holders, $24.5bn
Q2 20233 holders, $345m38 holders, $25.0bn
Q3 20237 holders, $301m37 holders, $18.9bn
Q4 20234 holders, $318m31 holders, $19.0bn
Q1 20246 holders, $133m32 holders, $19.7bn
Q2 20244 holders, $134m35 holders, $20.4bn
Q3 20243 holders, $119m28 holders, $22.3bn
Q4 20244 holders, $115m37 holders, $20.4bn
Q1 20253 holders, $109m32 holders, $20.5bn
Q2 20254 holders, $95m31 holders, $18.4bn
Q3 20255 holders, $58m32 holders, $23.7bn
Q4 20254 holders, $43m29 holders, $27.8bn
Q1 20262 holders, $34m34 holders, $35.6bn
Q2 20261 holders, $27m33 holders, $39.1bn
CNMD

Conmed Corp

Holders
5
Reported value
$58m
Buyers
3
Sellers
1

Breadth +2 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
32
Reported value
$23.7bn
Buyers
17
Sellers
13

Breadth +4 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2025

Among the 35 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only CNMD (3)

Moore Capital Management LP, PDT Partners LLC, Winton Group Ltd

Only JNJ (30)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Freestone Grove Partners LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, and 5 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →